Risk factors for completed suicide in schizophrenia

Journal of Clinical Psychiatry

Volumn 66, Issue 5, 2005, Pages 579-585

  Kuo, Chian Jue ^a,b   Tsai, Shang Ying ^a,b   Lo, Chun Hsuan ^a   Wang, Ying Ping ^a   Chen, Chiao Chicy ^a,b  

^a TAIPEI CITY PSYCHIATRIC CENTER   (Taiwan)

^b TAIPEI MEDICAL UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDEPRESSANT AGENT; CLOZAPINE; GAMMA GLUTAMYLTRANSFERASE; HEPATITIS B SURFACE ANTIGEN; RISPERIDONE; SEROTONIN UPTAKE INHIBITOR;

ADULT; ALCOHOLISM; ARTICLE; CASE CONTROL STUDY; CONTROLLED STUDY; DEATH CERTIFICATE; DEPRESSION; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; FAMILY HISTORY; FEMALE; GAMMA GLUTAMYL TRANSFERASE BLOOD LEVEL; HEPATITIS B; HUMAN; MAJOR CLINICAL STUDY; MALE; MENTAL DISEASE; PRIORITY JOURNAL; PSYCHIATRIC DIAGNOSIS; RISK FACTOR; SCHIZOPHRENIA; SUBSTANCE ABUSE; SUICIDE; SUICIDE ATTEMPT;

EID: 19544368303     PISSN: 01606689     EISSN: None     Source Type: Journal    
DOI: 10.4088/JCP.v66n0506     Document Type: Article

References (30)

1. Inskip HM, Harris EC, Barraclough B. Lifetime risk of suicide for affective disorder, alcoholism and schizophrenia. Br J Psychiatry 1998;172:35-37
2. Hu WH, Sun CM, Lee CT, et al. A clinical study of schizophrenic suicides: 42 cases in Taiwan. Schizophr Res 1991;5:43-50
3. Drake RE, Gates C, Cotton PG, et al. Suicide among schizophrenics: who is at risk? J Nerv Ment Dis 1984;172:613-617
4. Roy A. Suicide in chronic schizophrenia. Br J Psychiatry 1982;141:171-177
5. Breier A, Astrachan BM. Characterization of schizophrenic patients who commit suicide. Am J Psychiatry 1984;141:206-209
6. Allebeck P, Varla A, Kristajansson E, et al. Risk factors for suicide among patients with schizophrenia. Acta Psychiatr Scand 1987;76:414-419
7. Modestin J, Zarro I, Waldvogel D. A study of suicide of in schizophrenic in-patients. Br J Psychiatry 1992;160:398-401
8. Regier DA, Fanner ME, Rae DS, et al. Comorbidity of mental disorders with alcohol and other drug abuse: results from the Epidemiologic Catchment Area (ECA) Study. JAMA 1990;264:2511-2518
9. Yim PH, Yip PS, Li RH, et al. Suicide after discharge from psychiatric inpatient care: a case-control study in Hong Kong. Aust N Z J Psychiatry 2004;38:65-72
10. Heilä H, Isometsä ET, Henriksson MM, et al. Suicide and schizophrenia: a nationwide psychological autopsy study on age- and sex-specific clinical characteristics of 92 suicide victims with schizophrenia. Am J Psychiatry 1997;154:1235-1242
11. Hawton K. Assessment of suicide risk. Br J Psychiatry 1987;150:145-153
12. Tsai SY, Kuo CJ, Chen CC, et al. Risk factors for completed suicide in bipolar disorder. J Clin Psychiatry 2002;63:469-476
13. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, Third Edition. Washington, DC: American Psychiatric Association; 1980
14. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, Third Edition, Revised. Washington, DC: American Psychiatric Association; 1987
15. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition. Washington, DC: American Psychiatric Association; 1994
16. Egret for Windows [computer program]. Version 2.0.31. Cambridge, Mass: Cytel Software Corp; 1999
17. Hollingshead A, Redlich F. Social Class and Mental Illness. New York, NY: John Wiley & Sons Inc; 1958:220-250
18. Kendler KS, McGuire M, Gruenberg AM, et al. The Roscommon family study, 1: methods, diagnosis of probands and risk of schizophrenia in relatives. Arch Gen Psychiatry 1993;50:527-540
19. Wilkinson G, Bacon NA. A clinical and epidemiological survey of parasuicide and suicide in Edinburgh schizophrenics. Psychol Med 1984;14:899-912
20. World Health Organization. The ICD-10 Classification of Mental and Behavioural Disorders: Clinical Descriptions and Diagnostic Guidelines. Geneva, Switzerland: World Health Organization; 1992
21. Siris SG. Diagnosis of secondary depression in schizophrenia: implication for DSM-IV, Schizophr Bull 1991;17:75-98
22. Siris SG, Bermanzohn PC, Mason SE, et al. Maintenance imipramine therapy for secondary depression in schizophrenia. Arch Gen Psychiatry 1994;51:109-115
23. Levinson DF, Umapathy C, Musthaq M. Treatment of schizoaffective disorder and schizophrenia with mood symptoms. Am J Psychiatry 1999;156:1138-1148
24. Cohen LJ, Test MA, Brown RL. Suicide and schizophrenia: data from a prospective community treatment study. Am J Psychiatry 1990;147:602-607
25. Reid WH, Mason M, Hogan T. Suicide prevention effects associated with clozapine therapy in schizophrenia and schizoaffective disorder. Psychiatr Serv 1998;49:1029-1033
26. Walker AM, Lanza LL, Arellano F, et al. Mortality in current and former users of clozapine. Epidemiology 1997;8:671-677
27. Meltzer HY. Suicidality in schizophrenia: a review of the evidence for risk factors and treatment options. Curr Psychiatry Rep 2002;4:279-283
28. Sernyak MJ, Desai R, Stolar M, et al. Impact of clozapine on completed suicide. Am J Psychiatry 2001;158:931-937
29. Kunugi H, Takei N, Aoki H, et al. Low serum cholesterol in suicide attempters. Biol Psychiatry 1997;41:196-200
30. Kim YK, Lee HJ, Kim JY, et al. Low serum cholesterol is correlated to suicidality in a Korean sample. Acta Psychiatr Scand 2002;105:141-148